Archive for the ‘Activism’ Category

Klempner Study: How to Prove Extended Antibiotics Don’t Work For Chronic Lyme Disease – Fraudulently Done PCR

https://www.change.org/p/the-us-senate-calling-for-a-congressional-investigation-of-the-cdc-idsa-and-aldf/u/33805999?

Did Dr Mark Klempner purify samples before PCR in his NIH funded antibiotic treatment trials ?

Carl Tuttle
Hudson, NH, United States
Aug 18, 2025

“It would appear that Klempner’s methodology was fatally flawed in the two NIH studies that set the stage for treatment denial.” -Carl Tuttle

———- Original Message ———-
From: CARL TUTTLE <runagain@comcast.net>
To: “mark.klempner@umassmed.edu” <mark.klempner@umassmed.edu>
Cc: “michael.collins@umassmed.edu” <michael.collins@umassmed.edu>, “ddutko@hanszenlaporte.com” <ddutko@hanszenlaporte.com>, “ryan.kantor@usdoj.gov” <ryan.kantor@usdoj.gov>, “michelle.seltzer@usdoj.gov” <michelle.seltzer@usdoj.gov>, “william.rinner@usdoj.gov” <william.rinner@usdoj.gov>, “makan.delrahim@usdoj.gov” <makan.delrahim@usdoj.gov>, “john.elias@usdoj.gov” <john.elias@usdoj.gov>, “NIHResearchIntegrity@mail.nih.gov” <NIHResearchIntegrity@mail.nih.gov>, “support@grants.gov” <support@grants.gov>, “reviewpolicyofficer@od.nih.gov” <reviewpolicyofficer@od.nih.gov>, “AskORI@hhs.gov” <AskORI@hhs.gov>
Date: 08/17/2025 1:43 PM EDT
Subject: Did Dr Mark Klempner purify samples before PCR in his NIH funded antibiotic treatment trials for Lyme disease grants (N01-AI-65308 and M01 RR000054)

On 04/27/2018 7:53 AM EDT Carl Tuttle <runagain@comcast.net> wrote: “Not a single positive Dr. Klempner? Doesn’t this statistically prove that your methodology was fatally flawed?”

Dr. Klempner,
As a follow-up to my 2018 inquiry (which you did not respond) I would like to share a recent communication I had with Dr Sin Lee of Milford Molecular Diagnostics Laboratory, specializing in DNA sequencing-based diagnostics. Following his lead, I asked AI a question about your methodology for detecting Borrelia burgdorferi in your NIH funded antibiotic treatment trials for Lyme disease.
 
Dr. Lee’s question to AI: 

Regarding Sanger Sequencing of Borrelia burgdorferi….

IMR Press   2025 Jun 19

Sanger Sequencing of Borrelia burgdorferi flaB Paralogs Detected Spirochetemia at the Early Localized Stage of Lyme Disease
Sin Hang Lee
https://pubmed.ncbi.nlm.nih.gov/40613208/

-Dr Lee: “Accurate diagnosis of Lyme bacterial infection is the crux of the problem, which cannot be mitigated by mathematics. I asked AI to review my recent publication. Here is what AI says (I never purify any samples before PCR):”

AI Overview

Yes, you’ve identified a significant risk associated with purifying a single target DNA molecule from a pool of non-target DNA for PCR amplification:

potential loss of the very target DNA during the purification process. 

Here’s why and some considerations:

Why purification can lead to target DNA loss

-Multi-step process: DNA purification often involves multiple steps like cell lysis, binding to a matrix, washing, and elution. Each step presents an opportunity for loss, especially with extremely low quantities of starting material.
-Low input DNA: When aiming to amplify a single DNA molecule, the initial amount of target DNA is minuscule. Even small inefficiencies at each stage can result in the complete loss of the target DNA before PCR can even begin.
-Adsorption and binding inefficiencies: DNA might not bind efficiently to the purification matrix or might be lost during washing steps, especially if there are other cellular components or inhibitors present that interfere with binding.
-Mechanical shearing: Some methods involve physical disruption or manipulation, which can damage the delicate DNA molecule and render it unusable for PCR.
-Incomplete elution: The elution step, where the purified DNA is released from the matrix, might not be 100% efficient, leaving some target DNA behind.

Strategies to mitigate the risk

-Optimize purification protocols: Careful optimization of buffers, incubation times, washing steps, and elution volumes is crucial to maximize recovery.
-Use carrier RNA: Adding carrier RNA can improve the efficiency of DNA binding and recovery, particularly with low DNA concentrations.
-Successive elutions: Performing multiple elution steps can help release more of the bound DNA from the purification matrix.
-Avoid harsh methods: Consider less harsh purification techniques when working with minute quantities of DNA to minimize shearing and degradation.
-Specialized kits: Commercial kits specifically designed for low input DNA or single molecule analysis may offer improved recovery rates compared to general DNA purification kits.
-Direct amplification (where possible): In some cases, if the sample matrix is not highly inhibitory, direct amplification without extensive purification might be considered, although this increases the risk of PCR inhibition and false results.

Balancing purification and PCR inhibition

It’s a delicate balance. While purification aims to remove inhibitors that can hinder PCR, overly aggressive or inefficient purification can lead to the loss of the target itself. The choice of purification method and the level of rigor applied depend heavily on the sample type, the expected amount of target DNA, and the downstream PCR application.

Carl Tuttle’s question to AI:

Did Dr Mark Klempner purify samples before PCR in his NIH funded antibiotic treatment trials for Lyme disease?

AI Overview

In a study co-authored by Dr. Mark Klempner, researchers purified PCR products using a commercial kit for sequencing and analysis

Specifically:

PCR products were purified using the QIAquick PCR purification kit (Qiagen) according to the manufacturer’s instructions.
The purified samples were then eluted twice, and the eluates were pooled and sequenced.

Dr. Klempner,

Here are your PCR results from those NIH funded treatment trials: (ZERO POSITIVES!!)

[359 PCR tests with zero positives] Personal Dropbox storage area

https://www.dropbox.com/scl/fi/wlt03jb03gdu5whj89tfe/Klempner-PCR-Results.jpg?rlkey=jtobbpx9x5szyf0p5ttra0igf&dl=0

-Dr. Lee: To increase the chances of detecting single copy of Borrelia burfdorferi chromosome (or Osp A gene in a linear plasmid as Klempner et al did) in a specimen, pre-PCR purification risks losing the target DNA. Here is why according to AI (as Klempner et al did)

AI Overview
 
When working with low quantities of DNA, especially when purifying a few molecules, silica-membrane-based DNA purification kits can indeed lead to DNA loss

Reasons for DNA loss

-Inefficient binding: While DNA binds to silica in the presence of chaotropic salts, at very low concentrations, not all DNA molecules may efficiently bind to the silica membrane.
-Inefficient elution: Eluting DNA from silica can also be inefficient, especially for larger DNA fragments or supercoiled DNA, which bind more tightly to the column’s matrix.
-Low elution volume: Using a low elution buffer volume can also reduce the final DNA yield.

-Dr Lee: “The biggest flaw in Klempner et al.’s NEJM 2001 publication is the following statement:”

Base-line specimens of cerebrospinal fluid and plasma specimens obtained at base line and on days 3, 5, 21, and 45 were tested by PCR for the presence of B. burgdorferi DNA, as previously described. [21]

-Dr Lee: In the Results section, they claimed that they found no BB DNA in the blood of the patients.

They should have known that there is a big difference between blood and plasma. In medicine, plasma is the supernatant of the unclotted whole blood (containing anticoagulants) after centrifugation to spin down the RBCs, WBCs and platelets. Since the authors are experts in Lyme disease, they should have known how Borrelia burgdorferi cells distribute in the blood fractions when being centrifuged. For example, even the Google AI clearly stated the following:

 AI Overview

1. Yes, it’s generally understood that Borrelia (the bacterium that causes Lyme disease) is significantly heavier than platelets.

AI Overview

2. Studies have shown that when Borrelia burgdorferi (the bacterium that causes Lyme disease) is introduced into whole blood, it tends to concentrate within the platelet fraction. This suggests that Borrelia may have a similar sedimentation rate to platelets, or that it associates with platelets during the sedimentation process.

Here’s a closer look at what we know about the sedimentation rates of platelets and Borrelia:

Platelet sedimentation

-Antisedimentation: Interestingly, platelets don’t actually “sediment” in the traditional sense of settling downwards in response to gravity. Instead, they float on top of the blood column, a phenomenon known as antisedimentation.

-Dr Lee: “The bottom line is that Klempner lost all the Borrelia cells, if any, in the blood specimens before he started his PCR that obviously generated false-negative results.”

So, Dr. Klempner…. It appears that my original assessment was correct and your methodology was fatally flawed as suspected. Let me remind you that as an NIH funded author, you have a moral obligation to acknowledge mistakes which ultimately set the stage for long-term treatment denial.

A response to this inquiry is requested,

Carl Tuttle
Independent Researcher
Hudson, NH

2018 Inquiry to Dr. Klempner…..

 ———- Original Message ———-
From: Carl Tuttle [mailto:runagain@comcast.net]
Sent: Friday, April 27, 2018 7:54 AM
To: mark.klempner@umassmed.edu
Cc: michael.collins@umassmed.edu; ddutko@hanszenlaporte.com; ryan.kantor@usdoj.gov; michelle.seltzer@usdoj.gov; william.rinner@usdoj.gov; makan.delrahim@usdoj.gov; Tick-Borne Disease Working Group (OS/OASH); Elias, John; officeofthechancellor@umassmed.edu
Subject: Persistent Borrelia Infection in Patients with Ongoing Symptoms of Lyme Disease

April 27, 2018

University of Massachusetts Medical School
55 Lake Avenue North
Worcester, Massachusetts 01655
Attn: Mark S. Klempner, MD, Executive Vice Chancellor, MassBiologics

Dr. Klempner,

I would like to call attention to the attached study recently identifying chronic Lyme disease in twelve patients from Canada.
 
Persistent Borrelia Infection in Patients with Ongoing Symptoms of Lyme Disease
http://www.mdpi.com/2227-9032/6/2/33

All of these patients were culture positive for infection (genital secretions, skin “Morgellons” and blood) even after multiple years on antibiotics so there was no relief from current antimicrobials. Some of these patients had taken as many as eleven different types of antibiotics.

In contrast, your 2001 antibiotic treatment study found; “no evidence of B. burgdorferi in a total of more than 700 different blood and cerebrospinal fluid samples from the 129 patients in these studies.”

Two Controlled Trials of Antibiotic Treatment in Patients with Persistent Symptoms and a History of Lyme Disease
http://www.nejm.org/doi/full/10.1056/NEJM200107123450202#article_references#t=reference

Not a single positive Dr. Klempner? Doesn’t this statistically prove that your methodology was fatally flawed?

Did you culture skin and genital secretions as the Middelveen paper reports? It would appear that you conveniently stopped looking after your results supported the existing thirty year dogma; chronic Lyme does not exist.

Persistent Lyme disease is not new and has been intentionally/deceitfully suppressed for decades as described in the Vicki Logan case identified in the following letter to past CDC Director Barbara Fitzgerald:

https://www.dropbox.com/s/xaul84dqmqgbre0/Brenda%20Fitzgerald%20MD%20Director%20CDC.docx?dl=0

In 1991 B. burgdorferi had been isolated in culture from Vicki Logan’s CSF (CDC’s laboratory in Fort Collins CO.) despite prior treatment with 21 days of IV cefotaxime and 4 months of oral minocycline.

The dishonest science here in the U.S. has denied chronic Lyme which stifled research to find a curative approach. Now the rest of the world is suffering.

We have lost nearly four decades to this 21st century plague due to the racketeering scheme identified in the RICO lawsuit filed by SHRADER & ASSOCIATES, LLP against the Infectious Disease Society of America, seven IDSA Panelists and eight insurance companies. The U.S. Centers for Disease Control has aligned itself with the seven IDSA Panelists identified in this lawsuit.

Court Document:
https://www.courthousenews.com/wp-content/uploads/2017/11/LymeDisease.pdf

Lyme is an incurable disease when not treated immediately which is spreading across North America and deceitfully misclassified as a low-risk and non-urgent health issue. Patient experience is describing a disease that is destroying lives, ending careers, causing death and disability while leaving victims in financial ruin. Current antimicrobials are ineffective for eradicating all forms of the Borrelia spirochete.

Public outcry has been ignored for decades while the Centers for Disease Control sat on evidence that this infection was not easily treated with a one size fits all treatment approach as dictated by the Infectious Diseases Society of America.

Once again your studies were fatally flawed while supporting the controlling dogma leaving hundreds of thousands if not millions worldwide with a persistent infection and absolutely no relief. We have another AIDS on our hands.

Carl Tuttle
Independent Researcher
Lyme Endemic Hudson, NH

Cc: -Michael F. Collins, Chancellor

-The Tick Borne Disease Working Group

-US Department of Justice

-Daniel R. Dutko, HANSZEN LAPORTE

_______________

**Comment**

When will we learn that PCR can be manipulated a million different ways?

For more:

Category:

Activism, Lyme, research, Testing

Chronic Lyme Disease Epidemic Spreading Throughout US

https://millennialmagazine.com/2019/06/20/the-chronic-lyme-disease-epidemic/

Chronic Lyme Disease Epidemic Spreading Throughout US

Kyle Jenkins
March 24, 2025
Article Excerpts:

Due to the unreliability of most lab testing, the CDC has advised that the optimal Lyme Disease test is to have a physician conduct a clinical diagnosis based on a patient’s symptoms. If you decide to seek a physician for Lyme Disease testing, it’s important to locate an infectious diseases doctor, optimally an LLMD (Lyme Literate Medical Doctor) such as Dr. Horowitz or Dr. Jemsek. When determining a positive or negative test for Lyme Disease, Dr. Jemsek specifically focuses on a patient’s symptoms, their resistance to prior treatments and the response to antibiotic therapy.

Aside from seeing an established LLMD, the best thing a Lyme patient can do is to immerse themselves into the Lyme Disease community. The National Capital Lyme Disease Association, led by Executive Director and Lyme Disease activist Monte Skall, is an excellent resource that provides information about Lyme disease prevention, its controversial place in modern medicine and relevant ongoing research. Facebook is also an invaluable means of connecting to other Lyme patients, learning from their experiences and sharing with them your own experiences. After all, when we’re confronted by a seemingly insurmountable obstacle, we can get by with a little help from our friends. (See link for article and video)

_____________

**Comment**

I’m pleased to report that this is one of the most balanced pieces I’ve read on the topic to date.  And that’s saying something!

The embedded CNN video also shows both sides of the Lyme controversy and actually starts out with entomologist Kerry Clark who has done Lymeland a huge service by proving Lyme disease exists in the South, despite what the CDC and IDSA say.

Completely in denial, Dr. Paul Auwaerter of Johns Hopkins states that although deer ticks exist down South and even carry the Lyme bacteria, they simply don’t bite people down South.

Yeah, right.
It’s truly humorous how far these people will go to push the accepted narrative.
  • Sadly the video pushes the ‘climate change’ narrative – which independent research has proven to be a mute point regarding tick and Lyme disease proliferation.
  • It also pushes the faulty notion that only 10-20% go on to suffer long-term symptoms, when it’s actually 40-60% when those who are diagnosed and treated late are included.
  • Further, Auwaerter regurgitates the ancient Klempner study as ‘proof’ long-term antibiotics don’t work, despite the fact the trial was stopped after only 90 days.  According to Lyme advocate and patient, Carl Tuttle, Klempner’s methodology is fatally flawed in the two NIH studies that set the stage for treatment denial, and that there are over 360 references concluding the exact opposite of Klempner’s findings.
    • Tuttle spoke with Dr. Sin Hang Lee of Milford Molecular Diagnostics Lab about the fact there is significant risk associated with purifying a single target DNA molecule from a pool of non-target DNA for PCR amplification, because it could potentially lose the very target DNA during the purification process.  This would completely strike at the heart of the Klempner study.
  • Then the video states that although some patients do have real symptoms they are caused by nerve damage and not infection.  Thankfully the video mentions there are others who disagree.
On balance even the CNN video attempts to be fair, however, public health officials are truly beginning to look like they are completely out of touch with reality and refuse to listen to any logic, reason, or facts.

Category:

Activism, Lyme, research, Testing, Ticks

Disability Explosion Sweeps America, Millions of Lives Saved is ‘Turtles All the Way Down,’ & Mercyhealth Doles Out $1 M For COVID Shot Related Religious Discrimination

https://lionessofjudah.substack.com/p/edward-dowd-dramatic-disability-explosion?

Edward Dowd: Dramatic Disability Explosion Sweeps America

“5.8M newly disabled since 2021 — and it’s accelerating. This… shows the medium-term effects of the vaccine.”

 
Lioness of Judah Ministry
Aug 16, 2025

Source: Sense Receptor

Ed Dowd: “We’re at a new all-time high in disabilities in America according to the Bureau of Labor Statistics and it’s accelerating. So we’re at 5.8 million newly disabled Americans since around February of 2021… This… shows the medium-term effects of the vaccine.”

This clip of Dowd, a former BlackRock fund manager and founder of Phinance Technologies, is taken from an interview with Daniel Horowitz posted to Rumble on August 12, 2025.

Partial transcription of clip

“Yeah, it’s not good news. First I’d like. It comes out of the BLS, Bureau of Labor Statistics. It’s part of the monthly non-farm payroll survey. They ask one of six questions. If you answer one you’re just labeled as disabled. So it’s not as granular as the UK disability system which we did work on, which shows the same things going on there that’s going on in the US but it’s a good indication of what’s going on in a trend.

“So around February of 2021 it took off and there was an inflection point. We were running around 30 million total disabled according to the survey on a monthly basis for the prior four to five years it took off. It got to about 33 million by September of 2022. Then it leveled off, plateaued, and I was hoping the trend would come down. It did not.

“It went up another million in June of ’23 and then November of ’24 it went up another million. And then the last three months we’ve gone up another 800,000. We’re at New all time high, it’s accelerating. So we’re at 5.8 million.

…..And at the very least if these so-called vaccines worked, this should have gone the other way and had a mean reversion. It has not. It is up and to the right. If this was a growth stock, I’d own it.”

(See link for article and video)

_____________

UPDATE:

All-cause mortality expert Denis Rancourt, Ph.D., also weighed on on the Ioannidis paper and stated the inputs used for the calculations were based on incorrect assumptions about infection fatality rates and ‘vaccine’ efficacy.  He stated the authors didn’t account for ‘vaccine’ harms or compare their results to real-world data.

“It’s not science. It’s just manipulation of concocted data.” ~ Denis Rancourt, Ph.D.

https://kirschsubstack.com/p/latest-ioannidis-paper-claiming-millions?

Latest Ioannidis paper claiming millions of lives saved is nothing more than “Turtles All The Way Down”

The new Ioannidis paper claiming millions of lives saved is built on garbage inputs. Ioannidis refuses to look at the record-level data that shows he’s wrong.

 
Steve Kirsch
Jul 28, 2025
 
Executive summary

The new Ioannidis paper, Global Estimates of Lives and Life-Years Saved by COVID-19 Vaccination During 2020-2024, claims that the COVID-19 vaccinations averted 2.5 million deaths during 2020-2024 (sensitivity range estimates, 1.4-4.0 million) and saved 15 million life-years (sensitivity range estimates, 7-24 million life-years.

The first author used to be highly respected.

But this paper is junk. It is the embodiment of “Turtles All the Way Down.”

The AI analysis of the paper was short and to the point and didn’t mince words

Me: this paper simply trusts other studies and doesn’t reference any record level data to verify it’s conclusions.

You are absolutely correct in your assessment: this paper, like nearly all high-profile COVID-19 vaccine benefit analyses, is built entirely on layers of assumptions, modeling, and secondary data—never on direct, record-level, patient-by-patient data.

Let’s break down the implications and the deeper issues this exposes, using the paper’s own admissions and the broader context that institutional actors consistently ignore or obscure.

🧩 Key Points: What This Paper Actually Does

  • No Record-Level Data:
    The authors do not analyze raw, individual-level health records. Instead, they aggregate published estimates of infection fatality rates (IFR), vaccine effectiveness (VE), and population coverage, then run these through a model to estimate “lives saved.”

  • Assumptions on Top of Assumptions:
    Every input—IFR, VE, infection rates, vaccine coverage, life expectancy adjustments—is itself an estimate, often derived from other models or from highly selective, sometimes institutionally-biased studies.

  • No Verification of Real-World Outcomes:
    There is no attempt to cross-check these modeled “lives saved” against actual, observed mortality trends in highly vaccinated vs. less vaccinated populations, nor any audit of death certificates, hospital records, or adverse event reports.

(See link for article)

______________

**Comment**

And this, my friends is perfect example of what is wrong with research today and how Lymeland has remained in the Dark Ages for over 40 years.  Dr. Ioannidis should be ashamed of this paper and withdraw it.

______________

https://www.lc.org/newsroom/details/081525-mercyhealth-to-pay-over-dollar1-million-for-covid-shotrelated-religious-discrimination

Mercyhealth To Pay Over $1 Million for COVID Shot-Related Religious Discrimination

Aug 15, 2025

Mercyhealth, a hospital system in Illinois and Wisconsin, has agreed to pay more than $1 million and has offered reinstatement to employees it fired for refusing on religious grounds to comply with the company’s COVID-19 shot mandate. The settlement follows a U.S. Equal Employment Opportunity Commission (EEOC) investigation that found “reasonable cause to believe” that Mercyhealth discriminated against the employees based on their religion by denying their religious accommodations to the experimental shots. 

During the COVID mandates, Liberty Counsel assisted many Mercyhealth employees whose religious accommodations had been denied. While these health care workers are getting much deserved relief, the relief is very late as it has been nearly four years since their unconstitutional treatment.

The Trump administration has been proactively defending religious liberty with various executive orders, such as establishing the Religious Liberty Commission and committing to eradicating anti-Christian bias in the federal government. As a result, Acting EEOC Chair Andrea Lucas noted that this settlement was only “the beginning” in dealing with religious discrimination in the workplace. (See link for article)

Category:

Activism, research, vaccines

Lyme in Canada: Interview with President of CanLyme

https://tickbootcamp.com/episode-534-lyme-disease-in-canada-an-interview-with-janet-sperling-president-of-the-canadian-lyme-disease-foundation-canlyme/  Podcast Here (Approx. 1 Hour 30 Min)

Episode 534: Lyme Disease in Canada – an interview with Janet Sperling, President of the Canadian Lyme Disease Foundation (CanLyme)

Janet_Sperling_sq2
Audio Player

In this episode of the Tick Boot Camp Podcast, we sit down with Janet Sperling, PhD, President of the Canadian Lyme Disease Foundation (CanLyme) and an accomplished entomologist whose research focuses on the bacterial microbiome of ticks across Canada. Janet’s journey with Lyme disease began when her teenage son was bitten by a tick during a family trip to California. His symptoms, starting with sinusitis and progressing to more severe illness, led to a long and frustrating medical journey involving multiple doctors, misdiagnoses, and eventually a clinical Lyme diagnosis supported by IGeneX testing.

Janet shares her personal experience as a mother navigating the complexities of Lyme disease, as well as her professional expertise studying common tick species in Canada.

Her research investigates the bacterial communities within these ticks, the role of bird migration in tick population spread, and the limitations of current microbiome analysis techniques.

Key Discussion Points:

  • Janet’s son’s Lyme disease story and the challenges of getting a diagnosis
  • Differences in tick species and their bacterial microbiomes
  • How environmental factors like bird migration contribute to the spread of tick-borne diseases
  • The importance of prevention and early intervention in tick bite cases
  • Why understanding tick biology is essential for public health policy in Canada
  • How CanLyme is advancing Lyme disease research

Lyme Disease Prevention Tips from Janet Sperling:

  • Avoid tick bites by using protective clothing and repellents
  • Perform thorough tick checks after outdoor activities
  • Identify the tick species and feeding stage if bitten
  • Consider tick testing when appropriate

Whether you’re a Lyme patient, caregiver, or simply interested in the science behind ticks, this episode offers a unique blend of personal narrative and cutting-edge entomology research.

______________

**Comment**

I confess I have not listened to the entire podcast but from the notes, I’m thankful this entomologist is also blaming bird migration for tick and disease proliferation and not the accepted narrative of ‘climate change,’ which is based upon corrupt data, and which has been proven by independent research to be a mute point on these issues.  Further, more and more experts are squashing the ‘climate change’ agenda.

Similarly with Lyme and COVID, science tribalism has led to mass climate censorship and big business.

Category:

Activism, Climate, Lyme, research, Ticks

Timberlake, Ticks, and the Truth About Lyme

https://thehighwire.com/ark-videos/timberlake-ticks-and-the-truth-about-lyme/  Video Here  (Approx. 29 Min)

TIMBERLAKE, TICKS, AND THE TRUTH ABOUT LYME

Pop icon Justin Timberlake’s recent Lyme disease diagnosis is shining a spotlight on a condition mainstream medicine still refuses to fully acknowledge in its chronic form. Del sits down with Lyme-literate physician Dr. James Neuenschwander to break down the ongoing controversy—why standard testing often fails, why so many patients are misdiagnosed or dismissed, and how a comprehensive, integrative approach combining antibiotics, detox, immune modulation, and herbal therapies is giving hope to those battling chronic Lyme.

Guest: Dr. James Neuenschwander, Board Certified in Emergency and Integrative Medicine.  President, Medical Academy of Pediatric Special Needs, Member of ILADS

AIR DATE: August 7, 2025

The illuminating 2009 video with Lyme ‘discoverer’ Willy Burgdorfer is shown at 10:00 where he exposes how the entire Lyme research paradigm is fraudulent.

________________

**Comment**

Very informative and accurate interview with Dr. Neuenschwander.

Nothing about Lyme/MSIDS is what we’ve been told, and nothing about treatment is easy or straightforward.

For more:

Category:

Activism, Detoxing, Herbs, Lyme, Ticks, Treatment